• Latest Posts

Potential targets against natural killer/T-cell lymphoma found

Researchers identify gene expression signature to predict progression of type 1 diabetes

Molecular Partners presenting positive solid tumor data

UK invests £650M in life sciences

VarmX raises €30M for blood clotting trial

Novartis buys AVROBIO cystinosis gene therapy program for $87.5M

ADVERTISEMENT

Rocket Pharmaceuticals receives FDA designation for pyruvate kinase deficiency gene therapy

Transgene and BioInvent report positive solid tumor results

PharmEnable raises $7.5M to develop small molecule drugs to treat cancer and neurological diseases

Researchers discover genetic variation offers Alzheimer’s disease clues

smartbax raises €1.2M to create next-generation antibiotics

Major progress as Swedish scientists get brain tumors to self destruct

ADVERTISEMENT